The susceptibility to Fas-mediated apoptosis was evaluated in seven T-cell lines (two infected with HTLV-2, one with HTLV-1, and four HTLV-free) as well as in Jurkat cells transfected with a Tax-2 expressing vector. Fas-mediated apoptosis was significantly reduced in the HTLV-1-and HTLV-2-infected lines in comparison with the HTLV-free lines regardless of the surface expression of Fas antigen (which was no different in the infected and uninfected cells). Fas-mediated apoptosis was also significantly inhibited in Jurkat cells transfected with the Tax-2 expressing vector without any modification in Fas expression. There was significantly more antiapoptotic Bcl-x L mRNA and protein in the transfected than in the untransfected Jurkat T cells. In conclusion, our results suggest that HTLV-2 is capable of inhibiting Fas-mediated apoptosis by means of a mechanism involving the tax-2 gene and probably the expression of bcl-x L messenger and protein.
INTRODUCTION
Human T lymphotropic virus type 2 (HTLV-2) is an oncoretrovirus that is endemic in some American Indian populations and widespread among intravenous drug users (IVDUs) living in the USA and some European countries (Khabbaz et al., 1992; Zehender et al., 1996) .
The pathogenic role of HTLV-2 in any human disease is still under investigation. It has so far been associated with sporadic cases of a myelopathy resembling tropical spastic paraparesis/HTLV-associated myelopathy (TSP/ HAM) (Murphy et al., 1997; Berger et al., 1991a,b) , as well as with peripheral nerve disorders (Beilke et al., 1994; Dooneief et al., 1996) including a considerable percentage of cases of predominantly sensory polyneuropathy (PSP) occurring in the late stages of HIV-1 infection (Zehender et al., 1995) . Moreover, HTLV-2 is capable of transforming cells in vitro and causing spontaneous lymphocyte proliferation (Tarsis et al., 1998; Wiktor et al., 1991) . HTLV-2 has cell tropism for T cells, in particular CD8-positive cells. We have recently shown that HTLV-2 infects cells of the monocyte/macrophage lineage in patients with PSP and B lymphocytes (Zehender et al., 1998) . The mechanisms by which HTLV-2 may damage the nervous system and induce cell transformation are still obscure. Recent data have shown that human Tlymphotropic virus type 1 (HTLV-1) interferes with Fasmediated apoptosis. It has been suggested that a modification of the apoptotic pathway may be a pathogenic mechanism in HTLV-1-related lymphoproliferative, neurological and autoimmune diseases in humans (Arai et al., 1998; Copeland et al., 1994; Debatin et al., 1990; Guyot et al., 1996) and animal models (Kishi et al., 1997) .
The aim of this study was to investigate the influence of HTLV-2 infection on Fas-mediated apoptosis by analysing the susceptibility to apoptosis of human T-cell lines derived from HTLV-2-infected individuals and HTLV-2-negative cells transfected with a Tax-2 expressing vector. Finally, we compared the expression of pro-and antiapoptotic proteins of the Bcl-2 family in Tax-2 transfected or untransfected T cells.
RESULTS

T-cell line characterization and susceptibility to Fasmediated apoptosis
Susceptibility to Fas-mediated apoptosis was investigated in two HTLV-2-infected cell lines (MoT and C19), one HTLV-1-infected cell line (MT2), and four HTLV-free (Jurkat, CEM, Molt and H9) cell lines.
Phenotype characterization showed that all of the analyzed T-cell lines were CD4 and Fas antigen positive and CD8 negative. The percentage of Fas-expressing cells ranged from 51.4 to 97.0%, without any significant difference among the lines (Table 1) .
The presence of HTLV-1 proviral sequences in the MT2 and HTLV-2 proviral sequences in MoT and C19 was confirmed by PCR (data not shown). All of the other T-cell lines were negative for viral DNA or RNA sequences.
A high frequency of apoptosis (ranging from a mean of 67.5 Ϯ 6.3% to a mean of 96.6 Ϯ 1.2% by TUNEL assay) was induced in all of the HTLV-free T-cell lines after culturing in the presence of the anti-Fas monoclonal antibody. On the contrary, the HTLV-2-infected MoT and C19 cells showed a significantly lower level of apoptosis after anti-Fas treatment (mean values of 3.2 Ϯ 2.7 and 15.3 Ϯ 10% by TUNEL assay: P Ͻ 0.001 comparing the mean values of HTLV-free and HTLV-2-positive cells), similar to that of the HTLV-1-infected MT2 (17 Ϯ 18.3% by TUNEL assay) (Fig. 1) . The same results were obtained when the percentage of apoptotic cells was evaluated by fluorescence microscopy after Hoechst 33372 staining (Table 2) . Further TUNEL and Hoechst staining experiments gave similar results, and so only the TUNEL assay data are reported below.
No correlation was observed between the percentage of Fas-expressing cells and the percentage of apoptosis (correlation coefficient: 0.4; P ϭ 0.3 at Spearman's test).
Treatment of HTLV-free T cells with HTLV-2-positive supernatant
No significant difference was observed in the susceptibility to Fas-mediated apoptosis of the Jurkat cells treated with the MoT supernatants (56.1 Ϯ 8.7% using heat-inactivated and 59.1 Ϯ 11.8% using crude supernatant) and those treated with the H9 supernatant (69.5 Ϯ 12.2%; P ϭ 0.2).
Fas-mediated apoptosis in Jurkat cells transfected with a Tax-2 expressing vector
To investigate the possible role of HTLV-2 Tax protein in inhibiting Fas-induced apoptosis, we studied a T-cell line (Jurkat) transfected with a Tax-2 expressing vector.
Limiting dilution (LD) RT-PCR revealed a mean titer of 4.7 PU/10 3 cells of tax2/rex2 RNA after transfection. The 
Expression of bcl-2, bcl-x, and bax genes
The HTLV-2-infected MoT cells showed high levels of bcl-2, bcl-x L , and bax mRNAs (1.75 Ϯ 0.2, 1.75 Ϯ 0.1, and 1.3 Ϯ 0.7 PU/10 3 cells); the expression of bcl-x S mRNA was lower (0.18 Ϯ 0.007 PU/10 3 cells). The transfected Jurkat cells showed significant bcl-x L overexpression in comparison with the untransfected Jurkat cells (0.6 Ϯ 0.3 vs 0.075 Ϯ 0.09 PU/10 3 cells; P ϭ 0.03), but there was no significant difference in bcl-2 (0.75 Ϯ 0.63 vs 0.25 Ϯ 0.13 PU/10 3 cells; P ϭ 0.3), bcl-x S (0.25 Ϯ 0.12 vs 0.08 Ϯ 0.06 PU/10 3 cells; P ϭ 0.1), or bax messenger levels (0.43 Ϯ 0.32 vs 0.9 Ϯ 0.3 PU/10 3 cells; P ϭ 0.6) (Fig. 2) .
Interestingly, the ratio between the long and short bcl-x transcripts was, respectively, 1:1 and 3:1 in the untransfected and transfected Jurkat cells and 10:1 in the MoT cells.
Moreover, there was a marked inversion of the ratio between the bax and bcl-x L mRNA titers in the cells after transfection (12 before and 0.7 after transfection); a bax: bcl-x L ratio of 0.7 was observed also in Mot cells. Western blot analysis showed a higher concentration of Bcl-x L in the transfected than in the untransfected Jurkat cells (densitometric analysis revealed up to 3.5 times greater reactivity in the former; P ϭ 0.002) (Fig. 3a,b) . On the contrary, no difference was found in the expression of Bcl-2 or Bax proteins in the same cells by either Western blot or cytofluorimetric analysis (data not shown).
DISCUSSION
The apoptosis mediated by the Fas antigen plays a key role in the regulation of tissue turnover and the peripheral surveillance of immune tolerance (Nagata and Golstein, 1995) . Among its other functions, the Fas antigen participates in host defence against microorganisms, and virus-infected cells can be eliminated by Fasmediated apoptosis triggered by T-lymphocytes or NK cells. For this reason, a number of viruses (including herpesviruses, adenoviruses, and poxviruses) have developed still largely unexplored mechanisms that interfere with host cell apoptosis as a survival strategy (Meinl et al., 1998) . It is well known that the HTLV-1 and HIV-1 human retroviruses can affect the apoptotic pathway of infected cells (Meinl et al., 1998) , but conflicting results Note: Mean percent of apoptotic cells Ϯ SD. * P ϭ 0.002. have been reported concerning the effects of HTLV-1 infection on Fas-mediated apoptosis (Debatin et al., 1990; Arai et al., 1998; Copeland et al., 1994; Chen et al., 1997) . The observed discrepancies have been explained, suggesting that cell lines actively expressing HTLV-1 proteins are resistant, whereas infected cells not expressing HTLV-1 proteins (such as the majority of the cells derived from ATL patients) are susceptible to Fasmediated apoptosis (Arai et al., 1998; Copeland et al., 1994) . The inhibition of the apoptotic mechanism in HTLV-1-infected T-lymphocytes may play an important role in the pathogenesis of virus related lymphoproliferative diseases. Moreover, recent results have also shown increased resistance to Fas apoptosis in T cells derived from patients with TSP/HAM (Arai et al., 1998) and from transgenic mice carrying the env-pX region of HTLV-1 (which are highly susceptible to autoimmune arthropathy, a condition that is associated with HTLV-1 infection) (Kishi et al., 1997; Nishioka et al., 1996) .
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In this study, we found that human T-cell lines infected with HTLV-2 were resistant to Fas-mediated apoptosis to a similar or greater extent than the T-cell line infected with HTLV-1. The resistance was not due to the downregulation of Fas receptor. This result suggests that HTLV-2 can interfere with Fas-pathway in infected Tlymphocytes.
The in vitro infection of Jurkat cells with HTLVs is generally not very efficient (Hoffman et al., 1992; Kuroda et al., 1992) . In our experience, Jurkat cells exposed to the crude cell-free supernatant of MoT cells give only a small number of provirus-carrying cells (always Ͻ3%-data not shown), and this may explain why we did not observe any modification in the susceptibility of these cells to Fas-mediated apoptosis.
It has been reported that the inactivated supernatants of some HTLV-1-positive T-cell lines can transfer resistance to apoptosis to uninfected cells (Copeland et al., 1994) . The absence of any significant reduction in Fasmediated apoptosis in Jurkat cells after treatment with the crude or heat-inactivated MoT supernatant suggests that mere contact with virus particles or viral products is not sufficient to confer protection in the case of HTLV-2.
On the contrary, the Jurkat cells did develop resistance to Fas-mediated apoptosis after transfection with a Tax-2 expressing vector. Also in this case, the resistance to apoptosis was not due to the downregulation of surface Fas antigen. Our findings therefore suggest that, like its HTLV-1 counterpart, Tax-2 plays an important role in inducing resistance to Fas-mediated apoptosis in infected T-lymphocytes. Recent studies have shown that HTLV-2 is involved in the pathogenesis of some neurologic disorders resembling HTLV-1-associated TSP/HAM (Murphy et al., 1997) . Moreover, a possible role of HTLV-2 in T-cell lymphomas has also been recently suggested (Poiesz et al., 2000) . The resistance to apoptosis may significantly increase the life-span of infected T cells, possibly by playing a role in the pathogenesis of putative HTLV-2-associated disorders.
To clarify the mechanism of apoptosis inhibition caused by HTLV-2, we analyzed the expression of the messengers coding for some of the proteins belonging to the Bcl-2 family that play a key role in controlling of the apoptotic pathway (recently reviewed by Adams and Cory, 1998) . In particular, we considered the expression of the genes coding for Bcl-2, Bcl-x, and Bax in Tax-2 transfected or untransfected Jurkat cells and in the MoT cell line. Bcl-2 is one of the best-known proteins providing protection against apoptosis. Of the two sets of alternative spliced messengers produced by bcl-x, the long messenger (bcl-x L ) codes for a protein that is homologous to Bcl-2 and protects cells from apoptosis, whereas the short transcript (bcl-x S ) produces a protein lacking the aminoacid region of maximum identity with Bcl-2 and can enhance cell sensitivity to apoptosis (Minn et al., 1996) . We also studied the expression of bax mRNA, which produces a protein of 21 kDa capable of inhibiting both Bcl-2 and Bcl-x L by forming heterodimers (Adams and Cory, 1998) .
PCR and Western blot analyses showed that the expression of Bcl-x L was higher in the transfected than in the untransfected Jurkat cells; however, both had similar titers of bcl-2, bax, and bcl-x S transcripts. Bcl-x L was also overexpressed in MoT cell line.
The high bcl-x L /bcl-x S ratio observed in the transfected cells (3:1) and the chronically HTLV-2-infected line (10:1) suggest that HTLV-2 or Tax-2 can influence the splicing process of bcl-x transcripts. It has been suggested that the ratios between Bax and Bcl-2 or Bcl-x L play a role in apoptosis regulation (Aggarwal and Gupta, 1998) : our finding of an inversion of the bax/bcl-x L mRNA ratio in Jurkat cells after transfection further supports the possible role of Bcl-x L in protecting against Fas-mediated apoptosis. Unlike Brauweiler et al. (1997) , we did not find any significant reduction in bax mRNA in the Jurkat cells expressing Tax-2. Interestingly, Tsukahara et al. (1999) have recently reported that HTLV-1 Tax protein can induce resistance to apoptosis in a T-cell line after IL-2 deprivation by inducing the constitutive expression of Bcl-x L through the NF-kB pathway. These data suggest that HTLV-1 and HTLV-2 Tax proteins may share similar mechanisms inducing apoptosis resistance in infected T cells.
In conclusion, our findings indicate that HTLV-2 is capable of inhibiting Fas-mediated apoptosis by means of a mechanism involving tax-2 gene expression and an increase in the intracellular concentration of bcl-x L mRNA and protein. The pathogenic significance of this observation deserves further investigation. Additional studies are needed to evaluate whether the mechanism affecting apoptosis may be different in other cell types as is suggested by recent reports that WKAH rats infected by HTLV-1 develop HAM/TSP and show increased oligodendrocyte apoptosis in central and peripheral nervous tissues (Ohya et al., 1997; Tomaro et al., 1996) .
MATERIALS AND METHODS
Cell lines
HTLV-1-infected MT-2, HTLV-2-infected MoT and C19 (Gallo et al., 1991) , and HTLV-free H9, Jurkat, CEM, and Molt T-cell lines were cultured (0.5 ϫ 10 6 cells/ml) in RPMI 1640 supplemented with 2 mM of L-glutamine, penicillin 50 units/ml, streptomycin 50 g/ml, and 10% fetal calf serum. The cell lines were kept at 37°C in 5% CO 2 , and the culture medium was changed twice weekly.
Transfection
Permanent transfection of Jurkat cells was obtained using the entire coding sequence of HTLV-2 tax/rex contained in the expression vector pBC 20.2 driven by the CMV promoter.
The expression vector was co-transfected in Jurkat cells with the vector pCDNA III/AMP containing the neomycin resistance gene by means of electroporation (260 V and 960 F). The cells (5 ϫ 10 6 ) were suspended in 200 l of RPMI complete medium and 10 mM HEPES buffer before transfection. The transfected cells were cultured and selected using G418 1 mg/ml in culture for 1 week and then cloned at 5 cells/well and kept under selection with G418.
Culture of Jurkat cells in HTLV-2-positive cell-free supernatants
To study the transfer of Fas-mediated apoptosis resistance, we treated Jurkat cells for 48 h with MoT supernatant (untreated or inactivated at 56°C for 30 min) (Copeland et al., 1994) . HTLV-free supernatant from the H9 cell line was used as control. Briefly, 1 ϫ 10 6 cells were incubated for 48 h with 1 ml of the supernatants at 37°C and then, after washing with PBS, analyzed for Fas expression and apoptosis. The presence of viral genome in the MoT supernatant was proved by means of RTnested PCR.
Phenotype characterization
The expression of surface membrane molecules was determined by means of flow cytometric analysis using CD4 FITC, CD8 PE, and CD3 PerCP monoclonal antibodies (MoAbs) (Becton Dickinson, CA).
To determine Fas expression, an unconjugated MoAb (clone CH-11) was used with a fluorescein-conjugated secondary antibody. Briefly, 1 ϫ 10 6 cells were washed in PBS containing 1% FCS and 0.1% sodium azide, suspended in 100 l of PBS, stained with 2.5 g of anti-Fas, and incubated at 4°C for 30 min. The cells were then washed and suspended in 100 l of PBS, stained with the secondary antibody, and incubated for 20 min at 4°C. After a second wash, the cells were fixed in 1% paraformaldehyde for 30 min before analysis.
Fluorescence intensity was measured using a Coulter Elite flow cytometry equipped with a 15-mW, 488-nm air-cooled argon laser.
Fas-mediated apoptosis assay
One million effector cells were incubated in culture medium for 15 h at 37°C with or without an anti-Fas MoAb (clone CH-11). After a first set of experiments designed to optimize antibody concentration, we decided to use 100 ng/ml as this gave the best results in terms of apoptosis induction.
The cells were harvested in the presence of antibodies, washed in PBS supplemented with 1% FCS and 0.1% sodium azide, and suspended in the appropriate medium. An anti-Fas monoclonal antibody (clone ZB4) that blocks the apoptosis induced by the CH-11 clone was used to control specificity.
Apoptosis was determined by evaluating DNA fragmentation using in parallel Hoechst 33372 and the Tdtmediated dUTP nick end labeling (TUNEL) technique (Boehringer Mannheim, Mannheim, Germany). One million cells were suspended in PBS, stained with 4 g/ml Hoechst 33372 (Calbiochem, CA), and incubated for 30 min at 37°C. The apoptotic cells were evaluated by means of fluorescence microscopy.
For the TUNEL reaction, 1 ϫ 10 6 of anti-Fas stimulated cells were fixed in 4% paraformaldehyde, permeabilized in a solution of 0.1% Triton X-100 in 0.1% sodium citrate, and incubated for 1 h at 37°C in 50 l TUNEL mixture containing TdT and fluorescein dUTP; an equal aliquot of cells was incubated without TdT under the same conditions. The cells were then washed and analyzed by means of flow cytometry. The results are expressed as the mean values of at least three independent experiments.
HTLV nucleic acid detection and semiquantitation
The nucleic acids were purified using commercially available extraction kits following the protocol suggested by the manufacturer (High Pure PCR Template Preparation Kit and High Pure RNA Isolation Kit from Boehringer Mannheim). In brief, 2 ϫ 10 6 cells were suspended in optimal lysis/binding buffers containing guanidine-HCl and Triton X-100 and proteinase K (only for DNA extraction) in a Tris-HCl buffer. The nucleic acids were then extracted by means of centrifugation through a glass fiber fleece, and eluted using 50 l of nuclease-free sterile bidistilled water. The RNA-containing samples were finally digested with DNAse I. HTLV-2 proviral DNA and RNA levels were, respectively, determined by means of nested-PCR and nested-RT-PCR using primers amplifying a sequence included in the tax gene (sense outer primer position at nucleotides 7219-7238, antisense position 7483-7464; sense inner primer position 7248-7267; antisense position 7406-7386) as described elsewhere (Zehender et al., 1998) . The same primers were also used to detect HTLV-1 tax sequences (amplified region 7358-7516).
To differentiate HTLV-1 and HTLV-2 proviruses, a common HTLV-1/HTLV-2 sequence included in the pol gene was amplified by means of single-stage PCR or RT-PCR using primers flanking the region between nucleotides 4735 and 4920 and hybridized with specific HTLV-1 and HTLV-2 probes (position on HTLV-1 genome 4825-4850 and HTLV-2 genome 4880-4898).
The absence of contamination was verified by using a number of negative controls (DNA extracted from known HTLV-free blood-donor PBMCs) and blank tubes (not containing DNA) in each experiment.
To detect tax2/rex2 double-spliced mRNA, we developed a nested-RT-PCR using two pairs of primers amplifying a region containing the splice junction between exons 2 and 3 coding for Tax-2 and Rex-2 proteins. The outer and inner sense primers were located in exon 2 (positions 5128-5149 and 5157-5178); the outer and inner antisense primers were located in exon 3 (nucleotides 7483-7464 and 7406-7386) . The PCR protocol involved denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and elongation at 72°C for 1 min for a total of 40 cycles. The first and second steps were performed under the same conditions. The specificity of the amplified sequences was evaluated by means of micro-plate hybridization with a probe recognizing HTLV-tax (pos. 7337-7376) (Zehender et al., 1997) .
Semiquantitative PCR. The intracellular or supernatant concentrations of HTLV DNA and RNA were evaluated by means of limiting-dilution PCR, as previously described (Zehender et al., 1998) . Briefly, 2 g of DNA or 5 l of cDNA were serially diluted with each dilution being amplified by means of nested-PCR. The dilutions around the end point were retested in a five-replicate amplification and the concentration of nucleic acid calculated on the basis of the equation C ϭ Ϫln (N 0 /N T ), in which N 0 is the number of negative results and N T is the number of replicate experiments involving a single dilution.
The titer of the tax sequences was expressed as PCR units (PU-the smallest amount of target sequence giving a PCR signal) and related to 10 3 cells or 1 ml of supernatant. As previously described (Zehender et al., 1998) , the correspondence between the number of cells and the amount of amplified DNA, and the presence of any PCR-inhibitory substances, was evaluated in each sample by titrating a common sequence enclosed in the beta-globin gene using primers PC04 and GH20 (respectively, sense, pos. Ϫ73/Ϫ54 and antisense, pos. 195/176). A correlation coefficient of 0.8 was observed between the number of cells and the beta-globin titers (P Ͻ 0.01 by Spearman's test).
The efficiency of the RNA extraction was controlled by quantifying a ubiquitous messenger RNA coding for beta-actin (sense primer, pos. 1196/1227; antisense primer, pos. 1415/1384), which is constantly expressed in human cells.
Evaluation of nested-PCR sensitivity and LD-PCR efficiency. By amplifying different amounts of a plasmid containing the entire proviral genome of HTLV-2 (pMo4, kindly provided by Dr. G. Franchini of the National Cancer Institute, Bethesda, MD) dispersed in 1 g of human-HTLV-negative DNA, we observed a signal from about one copy of target molecule. The efficiency of the limiting-dilution-PCR protocol was evaluated by titrating known amounts of pMo4 in 1 g of human DNA. We found a correlation coefficient of 1 in a 5-log range between the titer and the number of amplified pMo4 copies (Zehender et al., 1998) .
Detection and semiquantitation of bcl-2, bcl-x, bax mRNAs by limiting-dilution RT-PCR. Two micrograms intracellular total RNA obtained as already described underwent cDNA synthesis by means of Oligo-(dT) and avian myeloblastosis virus (AMV) reverse transcriptase at 42°C for 60 min. Serial 10-fold dilutions of the cDNA were then amplified using the following primers: for bcl-2 detection, sense primer 5Ј-GGTGCCACCTGTGGTCCAC-CTG-3Ј, antisense 5Ј-CTTCACTTGTGGCCCAGATAGG-3Ј (fragment length, 459 bp) (Bargou et al., 1996) ; for bax detection, sense primer 5Ј-ATGGACGGGTCCGGGGAG-CAGCCC-3Ј and anti-sense 5Ј-GGTGAGCACTCCCGC-CACAAAGAT-3Ј (fragment length 615, bp) (Martinez-Valdez et al., 1995) . Bcl-x L and bcl-x S were simultaneously amplified using sense primer 5Ј-TTGGACAATGGACTG-GTTGA-3Ј and antisense 5Ј-GTAGAGTGGATGGTCAGTG-3Ј, leading to amplification products of, respectively, 780 and 591 bp (Bargou et al., 1996) . The amplifications were performed following the conditions suggested by Bargou et al. (1996) and Martinez-Valdez et al. (1995) .
The PCR products were revealed by means of ethidium bromide staining after agarose electrophoresis. Methods for the RNA titer calculation and expression has been described above (see HTLV-LD-PCR).
The efficiency of RNA extraction was evaluated by titrating in parallel the ubiquitous beta-actin mRNA in the same samples (see above).
Immunoblot analysis
The cells were lysed in a buffer containing 0.15 M NaCl, 50 mM Tris-HCl pH 8, 0.5% sodium deoxycholate (DOC), 1% N-P40, 0.1% SDS and protease inhibitors (Complete Protease Inhibitors Cocktail Tablets, Boehringer Mannheim). The cell proteins were denatured by means of the addition of an equal volume of sample buffer 2ϫ [100 mM Tris-base, pH 6.8, 4% sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol, 20% glycerol and 0.2% bromophenol blue], heated for 5 min at 100°C before separation by means of 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and subsequently transferred to a nitrocellulose membrane by means of electroblotting. The membranes were blocked in 10% non-fat dried milk, 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween 20 (TBS-T) for 1 h at room temperature and further incubated (overnight at 4°C) with the desired primary antibody. Anti-Bcl-2, anti-Bcl-x L and anti-Bax antibodies were diluted 1:5,000, and the membranes were then incubated with the appropriate biotin-conjugated secondary antibody (anti-rabbit, diluted 1:5,000). Antibody binding was visualised using a streptavidin horseradish peroxidase-conjugate diluted 1:10,000. The signal was elicited by means of the ECLϩ Plus Kit (Amersham Pharmacia Biotech, England) according to the manufacturer's instructions. Bands of reactivity were acquired using Fluor-S MultiImager (Bio-Rad, CA), and densitometric analysis was performed by Multi-Analyst software (Bio-Rad). The results of all of the experiments were confirmed three times.
Bcl-2 protein expression was also determined by flow cytometry. Briefly, the cells were fixed with ethanol 70%, permeabilized with PBS containing 0.1% saponin, and processed using a primary unconjugated anti-Bcl-2 antibody at 20 g/ml and a secondary FITC-conjugated anti-mouse antibody.
